BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

National Cancer Coalition (NCC) Announces Angel Grant Recipients


10/19/2005 5:11:05 PM

NEW ORLEANS, April 28 /PRNewswire/ -- The National Cancer Coalition (NCC) (http://www.nationalcancercoalition.org/ ) is pleased to announce its recent Angel Grant recipients, who include: Dr. Ben Carson of Johns Hopkins Medical Center, Dr. Daniel Von Hoff of the Arizona Cancer Center, Dr. Sue O'Dorisio of the University of Iowa, and Dr. Irwin Bernstein of the Fred Hutchinson Cancer Research Center.

Benjamin S. Carson, M.D., is the Director of Pediatric Neurosurgery at Johns Hopkins School of Medicine. Dr. Carson's Angel Grant will be used to conduct pre-clinical studies to examine the feasibility of a new therapy for brain tumor patients.

Daniel D. Von Hoff, M.D., is the Director of the Cancer Therapeutics Program at the Arizona Cancer Center of the University of Arizona. Dr. Von Hoff's grant from NCC will allow further pre-clinical experiments on loss-of- function mutations in cancer.

M. Sue O'Dorisio, M.D., Ph.D., is the Director of the Division of Pediatric Hematology / Oncology at the University of Iowa Health Care. Dr. O'Dorisio's grant will be used to provide assistance and counseling to the patients and their families participating in her NCI-sponsored Phase I clinical trial for children with neuroendocrine tumors.

Irwin D. Bernstein, M.D. is the Head of Pediatric Hematology/ Oncology at the Fred Hutchinson Cancer Research Center (FHCRC). Dr. Bernstein will use his grant to commence FHCRC's Pediatric Oncology Seminar Series.

The National Cancer Coalition implemented its Angel Grants program to provide seed funding to innovative projects that benefit and further cancer research, education, and programs. Grants are also awarded to act as a catalyst for scientists to secure additional funding from United States government agencies and other sources. The National Cancer Coalition is pleased to accept Angel Grant applications. For more information on Angel Grants and how to apply, please visit our website at: http://www.nationalcancercoalition.org/ .

The National Cancer Coalition, a 501(c)(3) not-for-profit corporation headquartered in New Orleans, conducts a variety of research, educational, prevention, and medical relief programs throughout the world. Through its Angel Grants program, NCC supports cutting-edge cancer research in the United States. The Coalition also sponsors community health fairs. In 2003, NCC's IMAP program provided pharmaceuticals and medical goods for its overseas medical relief projects in 10 countries within Latin America and Asia.

For additional information, please contact National Cancer Coalition at: 504-301-1461 or http://www.nationalcancercoalition.org/ .

National Cancer Coalition

CONTACT: National Cancer Coalition, +1-504-301-1461



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES